Deloitte Health Care

Deloitte Health Care


Your source of news and research from the Deloitte Center for Health Solutions and our Health Care Providers, Plans & Life Sciences practice.

75421 followers  •  916 follow  •    •   https://t.co/dFRFSKIwsL

Our new report explores how #healthplans  can use advanced consumer #analytics  to deliver measurable value to: 👨‍👩‍👦 members 👩‍⚕️ providers 💼 and associates Read more.

Considering #workplacehealth  risk management solutions #postCOVID ? Learn about MyPath to Work.

Learn more about #MyPathtoWork , which enables enhanced workplace safety protocols, visibility into risk factors, an agile response to changing health conditions, and more.

Are we at a new era of change in the cell and gene therapy industry? Our #HealthForward  blog explores the operational challenges CGT leaders will need to overcome.

From dabblers to pack leaders, see how different groups of #healthplans  are approaching consumer #analytics .

How can #analytics  help #healthplans  deepen connections with members, improve outcomes, and lower costs?

#Lifesciences made up nearly 40 percent of all IPOs from 2015 through mid-2019. Clearly the industry’s #accounting  teams need to be well-versed on IPO issues. They can start here.

As health systems look to recover from #COVID19 , where should health leaders focus? Discover key areas to consider in the HealthForward blog.

Loading
Loading

What do you think will have the biggest impact on the future of health? Visit us at #HIMSS19  (booth 3947) to experience what is coming next.

By 2040, health care as we know it today will no longer exist. What will define the future of health?

What’s ahead in 2016? Explore three significant trends impacting the life sciences and #healthcare  industry:

Will patients adhere to using connected health to monitor their conditions?

@CMSGov  will eliminate two-midnight rule pay cuts, proposes 0.7% pay bump for acute care hospitals #CHSCurrent 

What trends should #healthcare  leaders watch for in 2016? @DrMitchMorris  shares his thoughts direct from #HIMSS16 .

Drugs sourced via OI have a higher chance of later-phase clinical success #BIO2015 

tweet picture

Four questions #pharma  companies should ask when evaluating their #PatientEngagement  maturity levels.

What is the biggest #healthIT  development at @HIMSS ? @HarryGreenspun  shares his perspectives direct from #HIMSS16 .

Millennials are leading in utilizing #HealthIT  to measure their fitness & health #NHITweek 

tweet picture

Loading
Loading